In crisis? Call or text 988 for the Suicide & Crisis Lifeline, free and confidential, 24/7.  988lifeline.org
Modern Mental Health Edition No. 07 · A guide to seeking care early National · United States
Modern Mental Health Editorial Intelligence on Modern Care
The Guide From our survey Reviewed July 2026

Myths about searching online for depression help

The top result is not the best, most people do not find care by searching, and ketamine is not one thing: assumptions that shape searches.

A search engine is the most private place many people ever admit they are struggling. It is also a place where a handful of assumptions can quietly shape what you find, what you skip, and whether you ever take the next step.

Of the 443 Midwest adults in our survey, 319 answered a write-in question about what they would type when they wanted help. Combined with the rest of our survey, their responses let us check five common beliefs about searching online for depression help. Each percentage is a whole-sample figure from the panel's final, validated results.

Myth one: "If there were a better treatment, I would have come across it by now"

This belief feels logical. If something worked for depression that had not responded to medication, surely it would show up somewhere in all those searches.

The data says otherwise. Most people had never encountered the name of one such option. One is Spravato, a prescription nasal spray of esketamine that won FDA approval for use when standard treatment has not shifted depression. Seventy-three percent of the people we polled did not know the name. A fifth had the name in their ear with nothing attached to it, and only 6 percent knew what the spray actually is.

That is not because the option is secret. It is because it is usually described in clinical language, and people do not search in clinical language. Not having seen a treatment tells you very little about whether it exists or whether it might be worth asking about. A plain description of Spravato is a reasonable place to start.

Myth two: "Everyone else knows the right words to search"

If you have felt embarrassed that you typed something as simple as "depressed" or "help with depression," you are in good company. Those were typical answers. Others wrote "ptsd help," "best ways to handle depression," and "how to cope with my anxiety," and one simply pleaded, "someone please help me."

No phrase we have quoted names a medication or treatment. Plain words are how people ask for help. There is no insider vocabulary you are missing. When it comes time to talk to a clinician, your plain words are a fine place to start.

Myth three: "The top search result is probably the best one"

Search results, especially the first few, often include paid placements. A clinic that appears at the top may simply have bought that spot. That does not make it bad, but it does not make it the right fit either.

People seem to know this at some level. On the question of what would most push someone toward a newer depression treatment, respondents gave ads just 2 percent and podcast hosts 1 percent. The overwhelming answer, at 74 percent, was the person's own doctor.

If a result catches your eye, write it down and ask about it rather than treating it as a verdict. Look for a named, credentialed prescriber, clear information about what treatment is offered, and honest language about results.

Myth four: "Most people find treatment by searching"

Search is often where people start thinking about help. It is rarely where they say they would go to get it. Only 12 percent of our respondents would turn first to an online search for a newer depression treatment. Fifty-six percent would book with their primary doctor, while 23 percent would head to psychiatry.

That gap is useful. If you have been searching for weeks and feel stuck, it may not be because you have not found the right page. It may be because the next step needs a person across the table.

Myth five: "Ketamine is ketamine"

Searches like "depression medicine alternatives" and "ptsd treatments" can pull up many ketamine offerings, and it is easy to assume they are all the same thing. They are not.

  • Esketamine nasal spray carries FDA approval for adults whose depression outlasted other treatment. Certified sites give every dose, keep the patient under watch afterward, and send them home with another driver.
  • IV ketamine infusions are an off-label use for depression. They happen in clinics, but they are not the approved product.
  • At-home ketamine is prescribed by telehealth and taken without a clinician present. It is the furthest from supervised care.

Approval status matters to a lot of people: among our respondents, 59 percent would let FDA approval decide the choice or weigh on it heavily. And none of these is approved for PTSD, whatever a search result may imply. If an ad or site blurs these differences, that is a reason for caution.

A bonus belief: "I must be one of the few who needs this"

Searching alone at night can make depression feel like a solitary problem. The numbers suggest it is anything but. Fully 72 percent in our survey described depression, anxiety, or PTSD that standard pills could not fix, in themselves, in someone close, or in both. For 37 percent it was their own struggle.

Whatever you typed, many others have typed something very close.

What to do with your searches

  • Keep a short note of phrases you searched and anything that caught your interest.
  • Add the medications you have taken so far, with a word on each.
  • Check what your insurance covers. For 85 percent of our respondents, coverage was one of the two deciding traits in a provider.
  • Take all of it to a primary care visit or a mental health appointment and ask, in plain words, what options make sense for you.

If a search turned into a plea

If the words you would type right now are closer to "someone please help me," please do not keep searching. Put the phone to better use and dial 988, or text it, to reach the Suicide and Crisis Lifeline; veterans can press 1. When the danger is immediate, 911 comes first.

Limits

This article shares survey findings and general information about how treatments are delivered. Read it as background, not medical advice, and not as a claim that any treatment will help you; weighing that falls to whoever treats you.

Methodology

The publisher commissioned a Pollfish consumer panel survey and paid for it. It closed June 23, 2026, having collected 443 responses, every one from an adult 18 to 64, across Illinois, Nebraska, Missouri, Oklahoma, Wisconsin, Kansas, Ohio, Minnesota, Iowa, and Indiana. The search phrases, drawn from 319 answers, are quoted as written. We cite top-line percentages, and Pollfish has signed off on its validation of them.